{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:25:36Z","timestamp":1787235936212,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/inf.0b013e318241d09e","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T06:35:39Z","timestamp":1323930939000},"page":"124-128","source":"Crossref","is-referenced-by-count":28,"title":["Clinical Presentation of Invasive Pneumococcal Disease in Spain in the Era of Heptavalent Conjugate Vaccine"],"prefix":"10.1097","volume":"31","author":[{"given":"Maria F.","family":"de Sevilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Jos\u00e9","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Esteva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Moraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Selva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Ciruela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Planes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Codina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Salleras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mu\u00f1oz-Almagro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210202","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":". Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.","volume":"374","author":"OBrien","year":"2009","journal-title":"Lancet"},{"key":"R2-5-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":". Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part 1.","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R3-5-20210202","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":". Postlicensure surveillance for pneumococcal disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":". Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R5-5-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":". Emergence of invasive pneumococcal disease caused by non-vaccine serotypes in the era of 7-valent conjugate vaccine.","volume":"46","author":"Munoz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R6-5-20210202","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/313609","article-title":". The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R7-5-20210202","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10096-010-1086-9","article-title":". DNA bacterial load in children and adolescents with pneumococcal pneumonia and empyema.","volume":"30","author":"Munoz-Almagro","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R8-5-20210202","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1099\/jmm.0.2008\/000935-0","article-title":". Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children.","volume":"57","author":"Azzari","year":"2008","journal-title":"J Med Microbiol"},{"key":"R9-5-20210202","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/JCM.39.4.1553-1558.2001","article-title":". Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR.","volume":"39","author":"Corless","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R10-5-20210202","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10096-007-0350-0","article-title":". Evaluation of a real-time polymerase chain reaction assay for the diagnosis of pneumococcal and meningococcal meningitis in a tertiary care hospital.","volume":"26","author":"Van Gastel","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R11-5-20210202","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10096-006-0225-9","article-title":". Pneumolysin polymerase chain reaction for diagnosis of pneumococcal pneumonia and empyema in children.","volume":"25","author":"Lahti","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R12-5-20210202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CVI.00317-10","article-title":". Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar.","volume":"18","author":"Picazo","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"R15-5-20210202","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/JCM.35.3.764-766.1997","article-title":". Dot blot assay for the serotyping of pneumococci.","volume":"35","author":"Fenoll","year":"1997","journal-title":"J Clin Microbiol"},{"key":"R16-5-20210202","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1469-0691.2008.02028.x","article-title":". Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR.","volume":"14","author":"Tarrago","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"R17-5-20210202","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1099\/00221287-144-11-3049","article-title":"A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.","volume":"144","author":"Enright","year":"1998","journal-title":"Microbiology"},{"key":"R18-5-20210202","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/JB.186.5.1518-1530.2004","article-title":". eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data.","volume":"186","author":"Feil","year":"2004","journal-title":"J Bacteriol"},{"key":"R19-5-20210202","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1542\/peds.106.2.362","article-title":"Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.","volume":"106","year":"2000","journal-title":"Pediatrics"},{"key":"R20-5-20210202","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1128\/JCM.36.3.669-673.1998","article-title":". Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR.","volume":"36","author":"Dagan","year":"1998","journal-title":"J Clin Microbiol"},{"key":"R21-5-20210202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1542\/peds.2008-1702","article-title":". Serotype 19A is the most common serotype causing invasive pneumococcal infections in children.","volume":"125","author":"Kaplan","year":"2010","journal-title":"Pediatrics"},{"key":"R22-5-20210202","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3201\/eid1409.071094","article-title":". Pediatric parapneumonic empyema, Spain.","volume":"14","author":"Obando","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"R23-5-20210202","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1651-2227.2008.01080.x","article-title":". Invasive pneumococcal disease in Danish children, 1996-2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine.","volume":"98","author":"Winther","year":"2009","journal-title":"Acta Pediatr"},{"key":"R24-5-20210202","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.inf.0000202137.37642.ab","article-title":". Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.","volume":"25","author":"Byington","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R25-5-20210202","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":". Epidemiology of Streptococcus pneumoniae infections in the U.S., 1995-1998: opportunities for prevention in the conjugate vaccine era.","volume":"285","author":"Robinson","year":"2001","journal-title":"JAMA"},{"key":"R26-5-20210202","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal diseaseUnited States, 1998-2003.","volume":"54","year":"2005","journal-title":"Morb Mortal Wkly Rep"},{"key":"R27-5-20210202","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/CVI.00271-10","article-title":". PsrP, a protective pneumococcal antigen, is highly prevalent in children with pneumonia and is strongly associated with clonal type.","volume":"17","author":"Munoz-Almagro","year":"2010","journal-title":"Clin Vaccine Immunol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201202000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:30:38Z","timestamp":1786048238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201202000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318241d09e","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}